The sequence of the GPR120 exon in obese subjects reveals a deleterious non-synonymous mutation, which may attenuate beneficial n-3 PUFA effects and the secretion of glucagon-like peptide 1, leading to obesity [101]. Here, FFAR4 is linked to obesity disorder.